Birgitte Friedrichsen
9Patents
2h-index
24Co-inventors
43Inventor score
Filing activity: Jun 22, 2007 → Jul 31, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7932055B2 | Soluble heterodimeric CD94/NKG2 receptors fusion proteins | Physics | 6 | Active |
| US8163885B2 | Humanized antibodies against human interferon-alpha | Chemistry; Metallurgy | 2 | Active |
| US9737612B2 | Antagonistic DR3 ligands | Chemistry; Metallurgy | 0 | Active |
| US8658771B2 | Humanized antibodies against human interferon-alpha | Chemistry; Metallurgy | 0 | Active |
| US9713644B2 | Antagonistic DR3 ligands | Chemistry; Metallurgy | 0 | Active |
| US9127052B2 | LLT-1 antibodies with new functional properties | Chemistry; Metallurgy | 0 | Active |
| US8361463B2 | Humanized antibodies against human interferon-alpha | Chemistry; Metallurgy | 0 | Active |
| US8765130B2 | Antagonistic DR3 ligands | Chemistry; Metallurgy | 0 | Active |
| US9376496B2 | LLT-1 antibodies with new functional properties | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.